1. Home
  2. CWST vs TLX Comparison

CWST vs TLX Comparison

Compare CWST & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWST
  • TLX
  • Stock Information
  • Founded
  • CWST 1975
  • TLX 2015
  • Country
  • CWST United States
  • TLX Australia
  • Employees
  • CWST N/A
  • TLX N/A
  • Industry
  • CWST Environmental Services
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWST Utilities
  • TLX Health Care
  • Exchange
  • CWST Nasdaq
  • TLX Nasdaq
  • Market Cap
  • CWST 7.5B
  • TLX 6.0B
  • IPO Year
  • CWST 1997
  • TLX N/A
  • Fundamental
  • Price
  • CWST $118.50
  • TLX $17.18
  • Analyst Decision
  • CWST Strong Buy
  • TLX Strong Buy
  • Analyst Count
  • CWST 7
  • TLX 1
  • Target Price
  • CWST $122.67
  • TLX $22.00
  • AVG Volume (30 Days)
  • CWST 539.9K
  • TLX 25.5K
  • Earning Date
  • CWST 05-01-2025
  • TLX 01-01-0001
  • Dividend Yield
  • CWST N/A
  • TLX N/A
  • EPS Growth
  • CWST N/A
  • TLX 798.14
  • EPS
  • CWST 0.21
  • TLX 0.09
  • Revenue
  • CWST $1,633,376,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • CWST $17.45
  • TLX N/A
  • Revenue Next Year
  • CWST $6.94
  • TLX N/A
  • P/E Ratio
  • CWST $566.41
  • TLX $195.23
  • Revenue Growth
  • CWST 21.63
  • TLX 55.85
  • 52 Week Low
  • CWST $88.89
  • TLX $13.61
  • 52 Week High
  • CWST $120.69
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • CWST 58.41
  • TLX N/A
  • Support Level
  • CWST $113.92
  • TLX N/A
  • Resistance Level
  • CWST $121.24
  • TLX N/A
  • Average True Range (ATR)
  • CWST 3.21
  • TLX 0.00
  • MACD
  • CWST 0.11
  • TLX 0.00
  • Stochastic Oscillator
  • CWST 75.02
  • TLX 0.00

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: